BioLineRx Announces Positive Preclinical Results for Novel Treatment for Chronic Myeloid Leukemia

[PR Newswire] – TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today positive pre-clinical results for BL-8040 in a third indication – as a treatme more

View todays social media effects on BLRX

View the latest stocks trending across Twitter. Click to view dashboard

See who BioLineRx is hiring next, click here to view